Ott_a_246632 3061..3071
Jing Tian,Enqi Kong,Xiangyu Wang,Zhaoguang Xie,Cherry Yin,Yi Chang,Jim Jinn-Chyuan Sheu,Quan Hao,Li Sun
2020-01-01
Abstract:Department of Gynecological Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, People’s Republic of China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, People’s Republic of China; School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan 250200, People’s Republic of China; The Third School of Clinical Medicine, Southern Medical University, Guangzhou 510515, People’s Republic of China; Department of Maternity, Jinan Maternal and Child Health Hospital Affiliated to Shandong First Medical University, Jinan, 250001, People’s Republic of China; Department of Obstetrics and Gynecology, China Medical University Hospital, Taichung 40447, Taiwan; Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung 80424, Taiwan; Department of Biotechnology, College of Life Science, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; School of Chinese Medicine, China Medical University, Taichung 40402, Taiwan; Department of Health and Nutrition Biotechnology, Asia University, Taichung 41354, Taiwan; Department of Gynecological Oncology, Qingdao Central Hospital, The Second Affiliated Hospital of Medical College of Qingdao University, Qingdao, 266042, People’s Republic of China; Department of Gynecological Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, People’s Republic of China Background: Remodeling and spacing factor-1 (RSF-1) is an identified tumor biomarker